bioAffinity Technologies, Inc.
BIAF
$0.4698
-$0.0292-5.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.97M | -2.00M | -2.11M | -1.96M | -2.37M |
| Total Depreciation and Amortization | 153.60K | 151.30K | 151.10K | 149.60K | 148.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.10K | 185.70K | 286.20K | 283.70K | 234.50K |
| Change in Net Operating Assets | 902.00K | -45.40K | 140.60K | -817.50K | 373.60K |
| Cash from Operations | -1.68M | -1.71M | -1.53M | -2.35M | -1.62M |
| Capital Expenditure | 0.00 | -9.40K | -28.30K | -41.40K | 13.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -9.40K | -28.30K | -41.40K | 13.40K |
| Total Debt Issued | -96.90K | 261.90K | -900.00 | 27.70K | -- |
| Total Debt Repaid | -91.00K | -91.00K | -90.40K | -88.70K | -84.80K |
| Issuance of Common Stock | 2.21M | 1.50M | -- | 2.57M | -- |
| Repurchase of Common Stock | -- | -- | -494.90K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 495.00K | -495.00K | -- |
| Cash from Financing | 2.03M | 1.67M | -91.10K | 2.02M | -84.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 348.70K | -44.70K | -1.65M | -368.40K | -1.69M |